Population Analysis of <i>Escherichia coli</i> Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
Agnès B. Jousset, Laura Bouabdallah, A. Birer, Isabelle Rosinski‐Chupin, Jean-François Mariet, Saoussen Oueslati, Cécile Emeraud, Delphine Girlich, Philippe Glaser, Thierry Naas, Rémy A. Bonnin, Laurent Dortet
Abstract
Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase-producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.
Topics & Concepts
BiologyEscherichia coliGeneticsclone (Java method)PopulationMultilocus sequence typingMicrobiologyGenotypeGeneMedicineEnvironmental healthAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance